Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,665,388
+$329,744 QoQ
Shares Held
14,566
-5.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#1,513
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JACKSON SQUARE CAPITAL, LLC holds $34,281,243 across 7 Drug Manufacturers - General names. ABBV ranks #3 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,872 | $22,635,644 | |
| 2 | MRK |
Merck & Co., Inc.
|
34,686 | $4,457,151 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
14,566 | $3,665,388 | |
| 4 | JNJ |
Johnson & Johnson
|
7,767 | $1,972,584 | |
| 5 | NVS |
Novartis AG
|
3,643 | $570,930 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,490 | $546,813 | |
| 7 | AMGN |
Amgen Inc
|
1,195 | $432,733 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,665,388 | 14,566 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $3,335,644 | 15,337 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $3,502,751 | 15,330 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $3,550,434 | 15,334 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $3,268,582 | 17,609 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $3,508,412 | 16,745 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $2,893,666 | 16,284 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $5,092,219 | 25,786 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $4,327,621 | 25,231 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $8,541,036 | 46,903 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $7,231,210 | 46,662 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $7,121,788 | 47,778 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $6,169,690 | 45,793 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $8,998,667 | 56,464 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $6,856,789 | 42,428 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $5,661,514 | 42,184 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $6,075,550 | 39,668 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $4,719,022 | 29,110 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $3,233,758 | 23,883 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $2,187,064 | 20,275 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,865,543 | 16,562 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $1,604,253 | 14,824 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $1,401,950 | 13,084 | Shares | Sole | 2021-03-05 | |
| 2020-09-30 | $2,065,372 | 23,580 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $2,278,365 | 23,206 | Shares | Sole | 2020-08-18 | |
| 2020-03-31 | $42,209 | 554 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||